- Home
- DYN vs ARDT Comparison
DYN vs ARDT Comparison
Compare DYN & ARDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- ARDT
- Stock Information
- Founded
- DYN 1984
- ARDT 2001
- Country
- DYN United States
- ARDT United States
- Employees
- DYN N/A
- ARDT N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- ARDT
- Sector
- DYN Health Care
- ARDT
- Exchange
- DYN Nasdaq
- ARDT NYSE
- Market Cap
- DYN 3.4B
- ARDT 2.8B
- IPO Year
- DYN 2020
- ARDT 2024
- Fundamental
- Price
- DYN $28.39
- ARDT $16.63
- Analyst Decision
- DYN Strong Buy
- ARDT Buy
- Analyst Count
- DYN 9
- ARDT 10
- Target Price
- DYN $52.44
- ARDT $22.30
- AVG Volume (30 Days)
- DYN 1.0M
- ARDT 264.5K
- Earning Date
- DYN 11-12-2024
- ARDT 11-06-2024
- Dividend Yield
- DYN N/A
- ARDT N/A
- EPS Growth
- DYN N/A
- ARDT N/A
- EPS
- DYN N/A
- ARDT 0.64
- Revenue
- DYN N/A
- ARDT $5,705,817,000.00
- Revenue This Year
- DYN N/A
- ARDT $10.07
- Revenue Next Year
- DYN N/A
- ARDT $7.76
- P/E Ratio
- DYN N/A
- ARDT $25.77
- Revenue Growth
- DYN N/A
- ARDT 11.23
- 52 Week Low
- DYN $9.82
- ARDT $14.58
- 52 Week High
- DYN $47.45
- ARDT $20.72
- Technical
- Relative Strength Index (RSI)
- DYN 42.04
- ARDT N/A
- Support Level
- DYN $27.99
- ARDT N/A
- Resistance Level
- DYN $35.68
- ARDT N/A
- Average True Range (ATR)
- DYN 2.09
- ARDT 0.00
- MACD
- DYN 0.23
- ARDT 0.00
- Stochastic Oscillator
- DYN 9.12
- ARDT 0.00
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
About ARDT ARDENT HEALTH PARTNERS INC
Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.